Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 10, 2014 - Issue 4
Submit an article Journal homepage
796
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

A recombinant chimeric protein containing B chains of ricin and abrin is an effective vaccine candidate

Junhong Wang State Key Laboratory of Pathogen and Biosecurity; Institute of Microbiology and Epidemiology; Academy of Military Medical Sciences; Fengtai District, Beijing, PR China; Tianjin Key Lab for Biomarkers Occupational and Environmental Hazard; Medical College of Chinese People's Armed Police Force; Tianjin, PR China
,
Shan Gao State Key Laboratory of Pathogen and Biosecurity; Institute of Microbiology and Epidemiology; Academy of Military Medical Sciences; Fengtai District, Beijing, PR China
,
Tao Zhang State Key Laboratory of Pathogen and Biosecurity; Institute of Microbiology and Epidemiology; Academy of Military Medical Sciences; Fengtai District, Beijing, PR China
,
Lin Kang State Key Laboratory of Pathogen and Biosecurity; Institute of Microbiology and Epidemiology; Academy of Military Medical Sciences; Fengtai District, Beijing, PR China
,
Wuchun Cao State Key Laboratory of Pathogen and Biosecurity; Institute of Microbiology and Epidemiology; Academy of Military Medical Sciences; Fengtai District, Beijing, PR China
,
Na Xu Institute of Military Veterinary; Academy of Military Medical Sciences; Changchun, PR China
,
Wensen Liu Institute of Military Veterinary; Academy of Military Medical Sciences; Changchun, PR ChinaCorrespondence[email protected] [email protected]
&
Jinglin Wang State Key Laboratory of Pathogen and Biosecurity; Institute of Microbiology and Epidemiology; Academy of Military Medical Sciences; Fengtai District, Beijing, PR ChinaCorrespondence[email protected] [email protected]
 show all
Pages 938-944 | Received 02 Dec 2013, Accepted 15 Jan 2014, Published online: 07 Feb 2014

References

  • Surendranath K, Karande AA. A neutralizing antibody to the a chain of abrin inhibits abrin toxicity both in vitro and in vivo. Clin Vaccine Immunol 2008; 15:737 - 43; http://dx.doi.org/10.1128/CVI.00254-07; PMID: 18353919
  • Smallshaw JE, Richardson JA, Vitetta ES. RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol. Vaccine 2007; 25:7459 - 69; http://dx.doi.org/10.1016/j.vaccine.2007.08.018; PMID: 17875350
  • Han YH, Gao S, Xin WW, Kang L, Wang JL. A recombinant mutant abrin A chain expressed in Escherichia coli can be used as an effective vaccine candidate. Hum Vaccin 2011; 7:838 - 44; http://dx.doi.org/10.4161/hv.7.8.16258; PMID: 21817853
  • Smallshaw JE, Richardson JA, Pincus S, Schindler J, Vitetta ES. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin. Vaccine 2005; 23:4775 - 84; http://dx.doi.org/10.1016/j.vaccine.2005.04.037; PMID: 15961194
  • Kende M, Yan C, Hewetson J, Frick MA, Rill WL, Tammariello R. Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge. Vaccine 2002; 20:1681 - 91; http://dx.doi.org/10.1016/S0264-410X(01)00484-4; PMID: 11858879
  • Griffiths GD, Lindsay CD, Allenby AC, Bailey SC, Scawin JW, Rice P, Upshall DG. Protection against inhalation toxicity of ricin and abrin by immunisation. Hum Exp Toxicol 1995; 14:155 - 64; http://dx.doi.org/10.1177/096032719501400201; PMID: 7779439
  • Hu WG, Yin J, Chau D, Negrych LM, Cherwonogrodzky JW. Humanization and characterization of an anti-ricin neutralization monoclonal antibody. PLoS One 2012; 7:e45595; http://dx.doi.org/10.1371/journal.pone.0045595; PMID: 23049820
  • Hu WG, Yin J, Chau D, Hu CC, Lillico D, Yu J, Negrych LM, Cherwonogrodzky JW. Conformation-dependent high-affinity potent ricin-neutralizing monoclonal antibodies. Biomed Res Int 2013; 2013:471346; http://dx.doi.org/10.1155/2013/471346; PMID: 23484120
  • Yermakova A, Mantis NJ. Protective immunity to ricin toxin conferred by antibodies against the toxin’s binding subunit (RTB). Vaccine 2011; 29:7925 - 35; http://dx.doi.org/10.1016/j.vaccine.2011.08.075; PMID: 21872634
  • Vallera DA, Burns LJ, Frankel AE, Sicheneder AR, Gunther R, Gajl-Peczalska K, Pennell CA, Kersey JH. Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies. J Immunol Methods 1996; 197:69 - 83; http://dx.doi.org/10.1016/0022-1759(96)00127-5; PMID: 8890895
  • Smallshaw JE, Vitetta ES. A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity. Vaccine 2010; 28:2428 - 35; http://dx.doi.org/10.1016/j.vaccine.2009.12.081; PMID: 20074685
  • Smallshaw JE, Firan A, Fulmer JR, Ruback SL, Ghetie V, Vitetta ES. A novel recombinant vaccine which protects mice against ricin intoxication. Vaccine 2002; 20:3422 - 7; http://dx.doi.org/10.1016/S0264-410X(02)00312-2; PMID: 12213413
  • Wang L, Liu XF, Yun S, Yuan XP, Mao XH, Wu C, Zhang WJ, Liu KY, Guo G, Lu DS, et al. Protection against Helicobacter pylori infection by a trivalent fusion vaccine based on a fragment of urease B-UreB414. J Microbiol 2010; 48:223 - 8; http://dx.doi.org/10.1007/s12275-009-0233-4; PMID: 20437155
  • Mantis NJ. Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin. Adv Drug Deliv Rev 2005; 57:1424 - 39; http://dx.doi.org/10.1016/j.addr.2005.01.017; PMID: 15935880
  • Liu W, Xu N, Yuan H, Li S, Liu L, Pu Z, Wan J, Wang H, Chang Y, Li R. Immunomodulatory activity of recombinant ricin toxin binding subunit B (RTB). Int J Mol Sci 2013; 14:12401 - 10; http://dx.doi.org/10.3390/ijms140612401; PMID: 23765218
  • McLain DE, Lewis BS, Chapman JL, Wannemacher RW, Lindsey CY, Smith LA. Protective effect of two recombinant ricin subunit vaccines in the New Zealand white rabbit subjected to a lethal aerosolized ricin challenge: survival, immunological response, and histopathological findings. Toxicol Sci 2012; 126:72 - 83; http://dx.doi.org/10.1093/toxsci/kfr274; PMID: 21987460
  • Medina-Bolivar F, Wright R, Funk V, Sentz D, Barroso L, Wilkins TD, Petri W Jr., Cramer CL. A non-toxic lectin for antigen delivery of plant-based mucosal vaccines. Vaccine 2003; 21:997 - 1005; http://dx.doi.org/10.1016/S0264-410X(02)00551-0; PMID: 12547614

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.